Opdualag nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial Images
Generic Name: nivolumab/relatlimab
This medication has been identified as Opdualag nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial and is used for Melanoma. It belongs to the drug class antineoplastic combinations and is not a controlled substance.
Images of medication
Opdualag
- Generic Name
- nivolumab/relatlimab
- Strength
- nivolumab 240 mg and relatlimab 80 mg per 20 mL (12 mg and 4 mg per mL) vial
- Availability
- Prescription only
- Drug Class
- Antineoplastic combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-7125
See also:
More about Opdualag (nivolumab / relatlimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.